| Literature DB >> 24707107 |
Yuka Yokoi1, Ryuya Yanagihashi2, Katsuyuki Morishita1, Takayuki Fujiwara1, Koji Abe3.
Abstract
[Purpose] Acute development of local muscle fatigue and recovery often become large issues on sports fields. This study aimed to identify the effects of normobaric hyperoxia on the recovery of local muscle fatigue. [Subjects] Eleven healthy males participated in this study, and they all completed two protocols in a random order. [Methods] Subjects performed single-leg isometric knee extension at 70% of their maximum voluntary isometric contraction (MVIC) for as long as possible. Each participant was subsequently treated with one of two recovery conditions: 20.9% O2 or 30.0% O2 for 30 minutes. Afterwards, they performed an identical isometric task to measure the extent of their recovery. The following parameters were used to assess the degrees of muscle fatigue: MVIC, endurance time, surface electromyography (sEMG) power spectra, and changes in hemoglobin concentration using near-infrared spectroscopy (NIRS).Entities:
Keywords: Maximum voluntary isometric contraction; Near-infrared spectroscopy; Surface electromyography
Year: 2014 PMID: 24707107 PMCID: PMC3976026 DOI: 10.1589/jpts.26.455
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Fig. 1.Study protocol performed by subjects randomly participating in two recovery sessions on separate days: NOX and HOX between physical tasks 1 and 2. NOX = normobaric normoxia; HOX = normobaric hyperoxia; WA = warming-up; MVIC = maximum voluntary isometric contraction; REC-MVIC = MVIC after recovery session; PT = physical task; D = duration; sEMG = surface electromyography; MF = median frequency; NIRS = near-infrared spectroscopy.
Normalized mean values (%, ± SEM) of maximum voluntary isometric contraction (MVIC) in NOX and HOX before (MVIC-1 and MVIC-2) and after (REC-MVIC-1 and REC-MVIC-2) 30 minutes recovery time
| MVIC-1 | MVIC-2 | REC-MVIC-1 | REC-MVIC-2 | |
| NOX | 100.0 (0.0) | 84.6 (3.4)* | 89.7 (2.9) | 78.2 (4.1)* |
| HOX | 100.0 (0.0) | 86.8 (3.5)* | 99.8 (3.4)*† | 86.7 (4.3) *† |
Significantly different (*p < 0.05) from the value of MVIC-1 within the same group, and significantly higher (†p < 0.05) in HOX than NOX.
Time course changes in mean values (a.u., ± SEM) of oxy-hemoglobin (Oxy), deoxy-hemoglobin (Deoxy), and total hemoglobin (THb) of NOX and HOX during the 30-minute recovery sessions
| Oxy | Deoxy | THb | ||||
| time (min) | NOX | HOX | NOX | HOX | NOX | HOX |
| 1 | −0.9 (3.4) | 6.0 (3.7) | 3.1 (2.7) | 1.7 (4.4) | 2.2 (5.5) | 7.7 (3.8) |
| 2 | 0.5 (4.8) | 12.6 (7.1) | 1.7 (3.2) | 2.4 (6.1) | 2.2 (6.9) | 15.0 (6.1) |
| 3 | 4.9 (6.9) | 20.5 (9.1) | 2.5 (3.7) | −0.8 (6.5) | 7.5 (8.6) | 19.7 (7.2) |
| 4 | 2.7 (7.7) | 23.3 (10.1) | 2.4 (4.2) | −3.5 (7.3) | 5.0 (9.9) | 19.8 (6.7) |
| 5 | 1.3 (7.7) | 30.0 (9.6)* | 0.4 (6.1) | −1.6 (7.0) | 1.7 (12.8) | 28.3 (6.6) |
| 6 | 4.8 (7.9) | 33.4 (9.8)* | 0.2 (6.4) | −2.4 (5.8) | 5.0 (13.5) | 31.0 (7.1) |
| 7 | 7.1 (8.7) | 39.3 (11.1)* | −1.6 (5.8) | −4.5 (6.7) | 5.5 (14.1) | 34.8 (8.2)* |
| 8 | 2.0 (9.2) | 40.2 (10.6)* | 1.3 (5.4) | −2.3 (6.8) | 3.3 (13.8) | 37.9 (7.3)* |
| 9 | 0.7 (9.6) | 40.6 (10.2)*† | 3.0 (5.6) | 1.0 (7.1) | 3.7 (14.5) | 41.6 (7.0)* |
| 10 | 3.5 (12.0) | 38.4 (10.0)*† | 2.1 (5.7) | 2.2 (7.4) | 5.5 (16.6) | 40.7 (7.3)* |
| 11 | 1.3 (13.5) | 37.0 (10.2)* | 4.4 (4.9) | 2.9 (7.7) | 5.7 (17.1) | 39.9 (7.0)* |
| 12 | 1.6 (13.8) | 40.9 (10.4)* | 0.6 (4.9) | 1.8 (7.7) | 2.2 (17.7) | 42.7 (7.3)* |
| 13 | −0.4 (13.5) | 46.3 (9.2)*† | 2.2 (5.4) | 2.9 (7.2) | 1.8 (17.4) | 49.2 (6.6)*† |
| 14 | 1.6 (12.6) | 47.0 (9.3)*† | −2.1 (6.9) | 7.3 (7.8) | −0.5 (18.1) | 54.3 (6.1)*† |
| 15 | −6.0 (12.2) | 41.5 (9.3)*† | −0.3 (6.6) | 9.7 (7.9) | −6.3 (17.0) | 51.2 (7.7)*† |
| 16 | −0.3 (12.9) | 43.2 (9.5)*† | −2.9 (7.3) | 6.8 (8.0) | −3.3 (18.0) | 50.0 (8.1)*† |
| 17 | 0.8 (13.9) | 50.3 (10.6)*† | −3.3 (7.9) | 4.5 (8.6) | −2.5 (19.6) | 54.8 (8.5)*† |
| 18 | 2.9 (14.0) | 51.4 (10.8)*† | −2.8 (8.0) | 5.2 (8.9) | 0.1 (20.0) | 56.6 (7.5)*† |
| 19 | 1.5 (14.0) | 52.5 (10.3)*† | −1.9 (8.1) | 4.3 (8.9) | −0.4 (19.7) | 56.8 (7.7)*† |
| 20 | 0.8 (14.7) | 52.2 (11.2)*† | −0.1 (7.1) | 3.5 (9.7) | 0.7 (19.7) | 55.7 (9.3)*† |
| 21 | 4.0 (14.1) | 54.9 (12.2)*† | −2.0 (7.9) | 0.7 (10.3) | 2.0 (19.9) | 55.6 (9.5)*† |
| 22 | 8.9 (14.8) | 53.5 (11.5)*† | −1.6 (8.0) | 5.2 (9.3) | 7.3 (20.1) | 58.6 (8.6)* |
| 23 | 9.7 (15.8) | 54.2 (10.9)* | −3.4 (7.5) | 10.1 (9.3) | 6.4 (20.5) | 64.4 (9.9)*† |
| 24 | 7.3 (15.4) | 55.8 (12.3)* | −1.7 (7.9) | 5.1 (10.2) | 5.6 (20.2) | 61.0 (11.0)* |
| 25 | 5.3 (13.8) | 54.1 (11.3)*† | −2.0 (7.00) | 5.1 (10.3) | 3.3 (17.8) | 59.2 (10.4)*† |
| 26 | −5.3 (15.9) | 53.4 (10.7)*‡ | 2.8 (8.3) | 4.8 (10.4) | −2.5 (16.7) | 58.2 (10.0)*† |
| 27 | −1.9 (16.1) | 58.4 (12.2)*‡ | 2.0 (7.8) | 3.7 (10.6) | 0.1 (16.8) | 62.1 (9.9)*‡ |
| 28 | 1.4 (16.4) | 56.5 (11.1)*† | 3.8 (7.7) | 7.9 (10.0) | 5.2 (17.6) | 64.3 (8.9)*† |
| 29 | 7.8 (15.7) | 55.1 (11.1)*† | 0.8 (8.7) | 8.8 (10.2) | 8.6 (18.6) | 63.8 (10.8)*† |
| 30 | 4.1 (14.8) | 50.5 (12.4)*† | −4.1 (9.0) | 7.6 (10.8) | 0.0 (19.0) | 58.1 (12.5)*† |
| ANOVA | F(1, 29) = 4.767, p < 0.01 | F(1, 29) = 0.958, p = 0.412 | F(1, 29) = 5.172, p < 0.01 | |||
Significantly different (*p < 0.01) from the value of the 1st minute within the same group, and significantly higher (†p < 0.05, ‡p < 0.01) in HOX than NOX. a.u. = authorized unit.